Amacathera
Toronto, CA · Founded 2016 · 20 employees on LinkedIn · 3 known investors
AmacaThera is a biotech company developing a tunable injectable hydrogel drug-delivery platform, based on hyaluronic acid and methylcellulose, for localized and long-acting release of therapeutics such as small molecules, biologics, peptides, and cells. It partners with pharmaceutical companies to co-develop products across applications including post-surgical non-opioid pain management and oncology.
Founders & leadership
Amacathera was founded in 2016 by Mike Cooke and Molly Shoichet.
MC
Mike CookeCo-Founder & CEO
MS
Molly ShoichetCo-Founder & Chief Science Officer
Investors · 3
Frequently asked questions
- What does Amacathera do?
- AmacaThera is a biotech company developing a tunable injectable hydrogel drug-delivery platform, based on hyaluronic acid and methylcellulose, for localized and long-acting release of therapeutics such as small molecules, biologics, peptides, and cells. It partners with pharmaceutical companies to co-develop products across applications including post-surgical non-opioid pain management and oncology.
- Who founded Amacathera?
- Amacathera was founded by Mike Cooke, Molly Shoichet in 2016.
- Who are Amacathera's investors?
- Amacathera's investors include Lumira Ventures, Stand Up Ventures, Toronto Innovation Acceleration Partners.
- Where is Amacathera headquartered?
- Amacathera is headquartered in Toronto, CA.